Related Experiment Video
Updated: Jul 7, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
NUAK1 coordinates growth factor-dependent activation of mTORC2 and Akt signaling
Mario Palma1, Elizabeth Riffo2, Alejandro Farias2
1Laboratorio de Transducción de Señales y Cáncer, Departamento de Bioquímica y Biología Molecular, Facultad Cs. Biológicas, Universidad de Concepción, Concepción, Chile. mpalma@hsph.harvard.edu.
Background:
mTORC2 is a critical regulator of cytoskeleton organization, cell proliferation, and cancer cell survival. Activated mTORC2 induces maximal activation of Akt by phosphorylation of Ser-473, but regulation of Akt activity and signaling crosstalk upon growth factor stimulation are still unclear.
Results:
We identified that NUAK1 regulates growth factor-dependent activation of Akt by two mechanisms. NUAK1 interacts with mTORC2 components and regulates mTORC2-dependent activation of Akt by controlling lysosome positioning and mTOR association with this organelle. A second mechanism involves NUAK1 directly phosphorylating Akt at Ser-473. The effect of NUAK1 correlated with a growth factor-dependent activation of specific Akt substrates. NUAK1 induced the Akt-dependent phosphorylation of FOXO1/3a (Thr-24/Thr-32) but not of TSC2 (Thr-1462). According to a subcellular compartmentalization that could explain NUAK1's differential effect on the Akt substrates, we found that NUAK1 is associated with early endosomes but not with plasma membrane, late endosomes, or lysosomes. NUAK1 was required for the Akt/FOXO1/3a axis, regulating p21CIP1, p27KIP1, and FoxM1 expression and cancer cell survival upon EGFR stimulation. Pharmacological inhibition of NUAK1 potentiated the cell death effect induced by Akt or mTOR pharmacological blockage. Analysis of human tissue data revealed that NUAK1 expression positively correlates with EGFR expression and Akt Ser-473 phosphorylation in several human cancers.
Conclusions:
Our results showed that NUAK1 kinase controls mTOR subcellular localization and induces Akt phosphorylation, demonstrating that NUAK1 regulates the growth factor-dependent activation of Akt signaling. Therefore, targeting NUAK1, or co-targeting it with Akt or mTOR inhibitors, may be effective in cancers with hyperactivated Akt signaling.
Insights
NUAK1 kinase regulates growth factor-activated Akt signaling by controlling mTORC2 localization and directly phosphorylating Akt. Targeting NUAK1 may treat cancers with hyperactivated Akt signaling.
Area of Science:
- Cellular Biology
- Molecular Oncology
Background:
- The mechanistic target of rapamycin complex 2 (mTORC2) pathway is crucial for cell growth, survival, and cytoskeletal organization.
- While mTORC2 activates Akt kinase, the precise mechanisms regulating Akt activity and its crosstalk with other signaling pathways upon growth factor stimulation remain incompletely understood.
Purpose of the Study:
- To elucidate the role of NUAK1 in regulating growth factor-dependent Akt activation and signaling.
- To investigate the molecular mechanisms by which NUAK1 influences Akt activity and downstream targets.
- To assess the therapeutic potential of targeting NUAK1 in cancer.
Main Methods:
- Investigated NUAK1's interaction with mTORC2 components and its effect on mTOR localization.
- Assessed NUAK1's direct phosphorylation of Akt at Ser-473.
- Analyzed the impact of NUAK1 on specific Akt substrates like FOXO1/3a and TSC2.
- Examined NUAK1's subcellular localization using cell imaging techniques.
- Evaluated the role of the NUAK1-Akt axis in regulating gene expression and cancer cell survival upon epidermal growth factor receptor (EGFR) stimulation.
- Tested the efficacy of pharmacological inhibition of NUAK1 alone and in combination with Akt or mTOR inhibitors.
- Correlated NUAK1 expression with EGFR and Akt phosphorylation in human cancer tissues.
Main Results:
- NUAK1 regulates growth factor-dependent Akt activation through two mechanisms: controlling mTORC2 localization and directly phosphorylating Akt at Ser-473.
- NUAK1 specifically phosphorylates Akt substrates FOXO1/3a but not TSC2, correlating with its association with early endosomes.
- The NUAK1-Akt/FOXO1/3a axis regulates the expression of p21CIP1, p27KIP1, and FoxM1, impacting cancer cell survival upon EGFR stimulation.
- Pharmacological inhibition of NUAK1 enhanced cell death induced by Akt or mTOR inhibitors.
- NUAK1 expression positively correlates with EGFR expression and Akt Ser-473 phosphorylation in human cancers.
Conclusions:
- NUAK1 kinase controls mTOR subcellular localization and directly induces Akt phosphorylation, thereby regulating growth factor-dependent Akt signaling.
- Targeting NUAK1, alone or in combination with Akt or mTOR inhibitors, presents a potential therapeutic strategy for cancers exhibiting hyperactivated Akt signaling.
More Related Videos
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle
The JAK-STAT Signaling Pathway